Follow Us

Tag: Global rights

University of Bristol spinout Apitope regained the exclusive global rights to the company’s novel compound named as ATX-MS-1467, a potentially ...

Medgenera is a New York and New Delhi-based healthcare news publication company actively supported by 120,000 monthly readers and subscribers in 43 countries, including the healthcare professionals at the 14 out of 25 biggest pharmaceutical companies.